136 related articles for article (PubMed ID: 38261927)
1. Genetic surgery for a cystic fibrosis-causing splicing mutation.
Bulcaen M; Carlon MS
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101177. PubMed ID: 38261927
[No Abstract] [Full Text] [Related]
2. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
[TBL] [Abstract][Full Text] [Related]
4. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.
Nissim-Rafinia M; Aviram M; Randell SH; Shushi L; Ozeri E; Chiba-Falek O; Eidelman O; Pollard HB; Yankaskas JR; Kerem B
EMBO Rep; 2004 Nov; 5(11):1071-7. PubMed ID: 15472711
[TBL] [Abstract][Full Text] [Related]
5. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of cystic fibrosis mutations.
Tsui LC
Trends Genet; 1992 Nov; 8(11):392-8. PubMed ID: 1279852
[TBL] [Abstract][Full Text] [Related]
7. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
8. A splicing mutation (1898 + 1G-->T) in the CFTR gene causing cystic fibrosis.
Crawford J; Labrinidis A; Carey WF; Nelson PV; Harvey JS; Morris CP
Hum Mutat; 1995; 5(1):101-2. PubMed ID: 7537147
[No Abstract] [Full Text] [Related]
9. Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation.
Oren YS; Irony-Tur Sinai M; Golec A; Barchad-Avitzur O; Mutyam V; Li Y; Hong J; Ozeri-Galai E; Hatton A; Leibson C; Carmel L; Reiter J; Sorscher EJ; Wilton SD; Kerem E; Rowe SM; Sermet-Gaudelus I; Kerem B
J Cyst Fibros; 2021 Sep; 20(5):865-875. PubMed ID: 34226157
[TBL] [Abstract][Full Text] [Related]
10. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.
Pagani F; Buratti E; Stuani C; Baralle FE
J Biol Chem; 2003 Jul; 278(29):26580-8. PubMed ID: 12732620
[TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Bozon D; Kerem B; Markiewicz D; Durie P; Rommens JM; Tsui LC
Genomics; 1991 May; 10(1):229-35. PubMed ID: 1710599
[TBL] [Abstract][Full Text] [Related]
12. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers.
Ramalho AS; Beck S; Penque D; Gonska T; Seydewitz HH; Mall M; Amaral MD
J Med Genet; 2003 Jul; 40(7):e88. PubMed ID: 12843337
[No Abstract] [Full Text] [Related]
13. The 3120 +1G-->A splicing mutation in CFTR is common in Brazilian cystic fibrosis patients.
Cabello GM; Cabello EH JL; Fernande O; Harris A
Hum Biol; 2001 Jun; 73(3):403-9. PubMed ID: 11459421
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation c.1210-3C > G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis.
Zhao X; Liu K; Xu W; Xiao M; Zhang Q; Song J; Chen K; Liu Y; Tian X; Xu KF; Zhang X
Front Med; 2022 Feb; 16(1):150-155. PubMed ID: 34302615
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion.
Shibata S; Ajiro M; Hagiwara M
Cell Chem Biol; 2020 Dec; 27(12):1472-1482.e6. PubMed ID: 32905759
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
17. Rescue of common exon-skipping mutations in cystic fibrosis with modified U1 snRNAs.
Donegà S; Rogalska ME; Pianigiani G; Igreja S; Amaral MD; Pagani F
Hum Mutat; 2020 Dec; 41(12):2143-2154. PubMed ID: 32935393
[TBL] [Abstract][Full Text] [Related]
18. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
[TBL] [Abstract][Full Text] [Related]
19. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
[TBL] [Abstract][Full Text] [Related]
20. The relationship between genotype and phenotype in cystic fibrosis.
Kerem E; Kerem B
Curr Opin Pulm Med; 1995 Nov; 1(6):450-6. PubMed ID: 9363081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
